{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:37:35Z","timestamp":1784997455865,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.anl.2025.04.014","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:35:22Z","timestamp":1746794122000},"page":"307-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current treatment options for recurrent respiratory papillomatosis: A narrative review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-9590","authenticated-orcid":false,"given":"Shigeyuki","family":"Murono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2025.04.014_bib0001","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/MLG.0b013e31816a7135","article-title":"Recurrent respiratory papillomatosis: a review","volume":"118","author":"Derkay","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0002","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/INF.0000000000000551","article-title":"Diagnosis and management of recurrent respiratory papillomatosis","volume":"33","author":"Wilcox","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anl.2025.04.014_bib0003","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM198305263082104","article-title":"Laryngeal papillomavirus infection during clinical remission","volume":"308","author":"Steinberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2025.04.014_bib0004","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/lary.23327","article-title":"Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study","volume":"122","author":"Omland","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0005","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/lary.26005","article-title":"Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates","volume":"126","author":"Novakovic","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0006","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/coa.13016","article-title":"Age of diagnosis, incidence and prevalence of recurrent respiratory papollomaotosis \u2013 a South African perspective","volume":"43","author":"Seedat","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0007","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/lary.31932","article-title":"Nationwide survey on incidence and management of recurrent respiratory papillomatosis in Japan","volume":"135","author":"Murono","year":"2025","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/coa.12565","article-title":"Age of onset of recurrent respiratory papillomatosis: a distribution analysis","volume":"41","author":"San Giorgi","year":"2016","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0009","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00005537-199806000-00026","article-title":"A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis","volume":"108","author":"Derkay","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lary.26742","article-title":"Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort","volume":"128","author":"Benedict","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0011","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/lary.30036","article-title":"Prospective, multi-center study on the anatomic distribution of recurrent respiratory papillomatosis","volume":"132","author":"Benedict","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0012","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archotol.1995.01890120044008","article-title":"Task force on recurrent respiratory papillomatosis. A preliminary report","volume":"121","author":"Derkay","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0013","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archotol.130.9.1039","article-title":"American Society of Pediatric Otolaryngology members\u2019 experience with recurrent respiratory papillomatosis and the use of adjuvant therapy","volume":"130","author":"Schraff","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0014","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijporl.2005.12.003","article-title":"British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis","volume":"70","author":"Tasca","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/coa.12683","article-title":"Prevalence and management of recurrent respiratory papillomatosis (RRP) in the UK: cross-sectional study","volume":"42","author":"Donne","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0016","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.anl.2014.10.006","article-title":"Trends in the management of recurrent respiratory papillomatosis in Japan","volume":"42","author":"Murono","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2025.04.014_bib0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/coa.14245","article-title":"Current practice, safety and efficacy of interventions for recurrent respiratory papillomatosis: evidence from a UK registry","volume":"150","author":"Donne","year":"2025","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/00016489.2023.2169346","article-title":"Surgical outcome of different surgical modalities for adult recurrent respiratory papillomatosis","volume":"143","author":"Liu","year":"2023","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0019","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/lio2.871","article-title":"Comparing KTP and CO2 laser excision for recurrent respiratory papillomatosis: a systematic review","volume":"7","author":"Yang","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/coa.14023","article-title":"Safety of different surgical modalities for recurrent respiratory papillomatosis resection: a systematic review and meta-analysis","volume":"48","author":"Liu","year":"2023","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/0145561320960544","article-title":"Application of office-based 445 nm blue laser transnasal flexible laser surgery: a case series and review of practice","volume":"100","author":"Miller","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anl.2025.04.014_bib0022","first-page":"384","article-title":"The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice","volume":"58","author":"Neyts","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.anl.2025.04.014_bib0023","first-page":"7875","article-title":"Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs","volume":"61","author":"Murono","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.anl.2025.04.014_bib0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C","article-title":"Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]","volume":"54","author":"Snoeck","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.anl.2025.04.014_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.otohns.2006.09.007","article-title":"Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature","volume":"136","author":"Chadha","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.anl.2016.01.005","article-title":"Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan","volume":"43","author":"Murono","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2025.04.014_bib0027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/000348940811700702","article-title":"Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study","volume":"117","author":"McMurray","year":"2008","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0028","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00405-023-08279-0","article-title":"Intralesional cidofovir vs. bevacizumab for recurrent respiratory papillomatosis: a systemic review and indirect meta-analysis","volume":"281","author":"Zagzoog","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2023.07.017","article-title":"Intralesional cidofovir: a systematic review of administration protocols and long-term recurrence rates in adult and juvenile recurrent respiratory papillomatosis","author":"Pamonag","year":"2023","journal-title":"J Voice"},{"key":"10.1016\/j.anl.2025.04.014_bib0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00405-013-2358-7","article-title":"Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients","volume":"270","author":"Tjon Pian Gi","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0031","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jamaoto.2019.4029","article-title":"Evaluation of safety of intralesional Cidofovir for adjuvant treatment of recurrent Respiratory papillomatosis","volume":"146","author":"Hoesli","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0032","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000348940511400407","article-title":"Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis","volume":"114","author":"Rahbar","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/lio2.132","article-title":"Current and future management of recurrent respiratory papillomatosis","volume":"3","author":"Ivancic","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0034","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/000348941112001001","article-title":"Local injection if bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study","volume":"120","author":"Zeitels","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0035","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/lary.26662","article-title":"Systemic bevacizumab for recurrent respiratory papillomatosis: a national survey","volume":"127","author":"Best","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0036","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1007\/s00405-022-07388-6","article-title":"Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review","volume":"279","author":"Pogoda","year":"2022","journal-title":"Eur Arch Othrhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0037","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1002\/lary.29343","article-title":"Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement","volume":"131","author":"Sidell","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0038","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1002\/lary.31670","article-title":"A consensus statement on the administration of systemic bevacizumab in patients with recurrent respiratory papillomatosis","volume":"134","author":"Best","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0039","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.otorri.2020.12.001","article-title":"Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled pilot study","volume":"73","author":"Ablanedo-Terrazas","year":"2022","journal-title":"Acta Otorrinolaringol Esp (Engl Ed)"},{"key":"10.1016\/j.anl.2025.04.014_bib0040","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1002\/lary.26847","article-title":"The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis","volume":"128","author":"Ahn","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40425-019-0603-3","article-title":"Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis","volume":"7","author":"Allen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.anl.2025.04.014_bib0042","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systemic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2025.04.014_bib0043","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s12889-020-08753-y","article-title":"The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis","volume":"20","author":"Luk\u00e1cs","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.anl.2025.04.014_bib0044","first-page":"208","article-title":"A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program","volume":"217","author":"Novakovic","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anl.2025.04.014_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cid\/ciab171","article-title":"Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States","volume":"73","author":"Meites","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anl.2025.04.014_bib0046","first-page":"47","article-title":"Australian Paediatric Surveillance Unit (APSU) annual surveillance report 2022","author":"Teutsch","year":"2023","journal-title":"Commun Dis Intell (2018)"},{"key":"10.1016\/j.anl.2025.04.014_bib0047","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/adc.2010.198184","article-title":"Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination","volume":"96","author":"Mudry","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anl.2025.04.014_bib0048","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00405-013-2755-y","article-title":"Clinical efficiency of quadrivalent HPV (types 6\/11\/16\/18) vaccine in patuents with recurrent respiratory papillomatosis","volume":"271","author":"Chiril\u0103","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0049","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00405-014-3143-y","article-title":"Human papilloma virus caccination in patients with an aggressive course of recurrent respiratory papillomatosis","volume":"271","author":"Ho\u010devar-Bolte\u017ear","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0050","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/infdis\/jiy616","article-title":"Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis","volume":"219","author":"Rosenberg","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anl.2025.04.014_bib0051","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/lary.30560","article-title":"The efficacy of human papillomavirus vaccination as an adjuvant therapy in recurrent respiratory papillomatosis","volume":"133","author":"Ponduri","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0052","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaoto.2022.1190","article-title":"Outcomes after human papilloma virus vaccination in patients with recurrent respiratory papillomatosis: a nonrandomized clinical trial","volume":"148","author":"Smahelova","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surgery"},{"key":"10.1016\/j.anl.2025.04.014_bib0053","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/lary.30749","article-title":"Interim results of a phase 1\/2 open-label study of INO-3107 for HPV-6 and\/or HPV-11-associated recurrent respiratory papillomatosis","volume":"133","author":"Mau","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0054","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41467-025-56729-6","article-title":"DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1\/2 study assessing efficacy, safety, and immunogenicity of INO-3107","volume":"16","author":"Morrow","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.anl.2025.04.014_bib0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-2600(24)00368-0","article-title":"PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1\/2 clinical trial","volume":"13","author":"Norberg","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.anl.2025.04.014_bib0056","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/00034894241264388","article-title":"Adjuvant intralesional bevacizumab in pediatric and adult populations with recurrent respiratory papillomatosis: a systematic review","volume":"133","author":"Gately","year":"2024","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0057","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12070-022-03204-z","article-title":"Intralesional Bevacizumab as adjuvant therapy for juvenile onset recurrent respiratory papillomatosis: a systematic review","volume":"75","author":"Guragain","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2022.111314","article-title":"Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis","volume":"162","author":"Park","year":"2022","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0059","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/lary.29084","article-title":"Systemic bevacizumab (Avastin) for juvenile-onset recurrent respiratory papillomatosis: a systematic review","volume":"131","author":"Ryan","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2025.04.014_bib0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0003489420949586","article-title":"Recurrent respiratory papillomatosis office versus operating room: systematic review and meta-analysis","volume":"130","author":"Chen","year":"2021","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0061","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0194599816683384","article-title":"A systematic review","volume":"156","author":"Drejet","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0062","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijporl.2012.12.027","article-title":"Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis","volume":"77","author":"Clamp","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0063","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1213\/ANE.0000000000006521","article-title":"Transnasal humidified rapid insufflation ventilatory exchange augments oxygenation in children with juvenile onset recurrent respiratory papillomatosis during surgery: a prospective randomized crossover controlled trial","volume":"137","author":"Lei","year":"2023","journal-title":"Anesth Analg"},{"key":"10.1016\/j.anl.2025.04.014_bib0064","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/014556131209100411","article-title":"Topical measles-mumps-rubella vaccine in the treatment of recurrent respiratory papillomatosis: results of a preliminary randomized, controlled trial","volume":"91","author":"Lei","year":"2012","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anl.2025.04.014_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJM198808183190704","article-title":"Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial","volume":"319","author":"Healy","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2025.04.014_bib0066","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0196-0709(88)80023-1","article-title":"The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study","volume":"9","author":"Bell","year":"1988","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.anl.2025.04.014_bib0067","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archotol.1988.01860220097032","article-title":"Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis","volume":"114","author":"Leventhal","year":"1988","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2025.04.014_bib0068","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1288\/00005537-198803000-00020","article-title":"Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions","volume":"98","author":"Kashima","year":"1988","journal-title":"Laryngoscope"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814625000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814625000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T02:18:05Z","timestamp":1756347485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814625000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0385814625000756"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2025.04.014","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current treatment options for recurrent respiratory papillomatosis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2025.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}